Artisan Partners Limited Partnership Reata Pharmaceuticals Inc Transaction History

Artisan Partners Limited Partnership

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$24.12 - $39.6 $3.89 Million - $6.39 Million	-161,346 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$25.61 - $110.96 $11,883 - $51,485	-464 Reduced 0.29%	161,346 $4.26 Million
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $293,200 - $419,334	2,932 Added 1.85%	161,810 $16.3 Million
Q2 2021 Aug 12, 2021	BUY	$78.27 - $151.29 $3.85 Million - $7.45 Million	49,225 Added 44.89%	158,878 $22.5 Million
Q1 2021 May 11, 2021	BUY	$94.25 - $132.81 $248,254 - $349,821	2,634 Added 2.46%	109,653 $10.9 Million
Q4 2020 Feb 10, 2021	BUY	$102.03 - $184.62 $10.9 Million - $19.8 Million	107,019 New	107,019 $13.2 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.